An Reduced Plasma Membrane Ca 2+ -atpase Function in Platelets from Patients with Non-insulin-dependent Diabetes Mellitus Letters to the Editor

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Thalidomide protects endothelial cells from doxorubicin‐induced apoptosis but alters cell morphology—reply to a rebuttal

  2005cited by this paper
• Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin‐alpha

  2003cited by this paper
• DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma.

  2003cited by this paper
• Targeting the Endothelium in Cancer : Clinical Implications

  2003cited by this paper
• Breast cancer trial with erythropoietin terminated unexpectedly.

  2003cited by this paper
• Thalidomide and thrombosis in multiple myeloma

  2003cited by this paper
• Thalidomide in multiple myeloma: current status and future prospects

  2003cited by this paper
• Erythropoietin Triggers a Signaling Pathway in Endothelial Cells and Increases the Thrombogenicity of their Extracellular Matrices In Vitro

  2002cited by this paper
• Diabetes mellitus: a hypercoagulable state.

  2001cited by this paper
• Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus.

  2001cited by this paper
• The role of platelets in diabetes-related vascular complications.

  2000cited by this paper
• Regulation of Plasma Membrane Ca2+-ATPase by Small GTPases and Phosphoinositides in Human Platelets*

  2000cited by this paper
• Stem cell transplantation

  1999cited by this paper
• Antitumor activity of thalidomide in refractory multiple myeloma.

  1999cited by this paper
• Regulation of Platelet Plasma Membrane Ca2+-ATPase by cAMP-dependent and Tyrosine Phosphorylation*

  1997cited by this paper
• Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of "syndrome X".

  1993cited by this paper
• Platelet free Ca2+ concentration in non-insulin-dependent diabetes mellitus.

  1991cited by this paper
• Calcium signaling in human platelets.

  1990cited by this paper
• Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage

  1989cited by this paper
• A new generation of Ca2+ indicators with greatly improved fluorescence properties.

  1985cited by this paper

• No citing papers are available for this paper.